Selected research
Market Structure
Global Topical Acne Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Topical Acne Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Topical Acne Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Topical Acne Medication include Teva, Mylan, GlaxoSmithKline, Sun Pharma, Sine Pharma, Mayne Pharma, Lion, HUAPONT and Galderma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Topical Acne Medication market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Topical Acne Medication and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Topical Acne Medication revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Topical Acne Medication market size, projected growth trends, production technologies, key applications, and end-use industries.
Topical Acne Medication Segment by Company
Teva
Mylan
GlaxoSmithKline
Sun Pharma
Sine Pharma
Mayne Pharma
Lion
HUAPONT
Galderma
Bausch Health
Almirall
Topical Acne Medication Segment by Type
Prescription Medicine
Over-the-counter (OTC) Medicine
Topical Acne Medication Segment by Application
Inflammatory Acne
Non-inflammatory Acne
Topical Acne Medication Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Acne Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Acne Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Acne Medication.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Topical Acne Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Acne Medication industry.
Chapter 3: Detailed analysis of Topical Acne Medication companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Acne Medicationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription Medicine
- Over-the-counter (OTC) Medicine
Applications
- Inflammatory Acne
- Non-inflammatory Acne
Companies covered
- Teva
- Mylan
- GlaxoSmithKline
- Sun Pharma
- Sine Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Galderma
- Bausch Health
- Almirall
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Topical Acne Medication Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Prescription Medicine
- 1.2.3 Over-the-counter (OTC) Medicine
- 1.3 Market Analysis by Application
- 1.3.1 Global Topical Acne Medication Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Inflammatory Acne
- 1.3.3 Non-inflammatory Acne
- 1.4 Global Market Growth Prospects
- 1.5 Global Topical Acne Medication Growth Trends by Region
- 1.5.1 Global Topical Acne Medication Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Topical Acne Medication Market Size by Region (2021-2026)
- 1.5.3 Topical Acne Medication Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Topical Acne Medication Market Dynamics
- 2.1 Topical Acne Medication Industry Trends
- 2.2 Topical Acne Medication Industry Drivers
- 2.3 Topical Acne Medication Industry Opportunities and Challenges
- 2.4 Topical Acne Medication Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Topical Acne Medication Revenue by Company (2021-2026)
- 3.2 Global Topical Acne Medication Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Topical Acne Medication Key Company Head office and Area Served
- 3.4 Global Topical Acne Medication Company, Product Type & Application
- 3.5 Global Topical Acne Medication Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Topical Acne Medication Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Topical Acne Medication Players Market Share by Revenue in 2025
- 3.6.3 2025 Topical Acne Medication Tier 1, Tier 2, and Tier 3
4 Topical Acne Medication Market by Type
- 4.1 Global Topical Acne Medication Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Topical Acne Medication Market Size by Type (2021-2032)
- 4.3 Global Topical Acne Medication Market Size Share by Type (2021-2032)
5 Topical Acne Medication Market by Application
- 5.1 Global Topical Acne Medication Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Topical Acne Medication Market Size by Application (2021-2032)
- 5.3 Global Topical Acne Medication Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teva Topical Acne Medication Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Mylan
- 6.2.1 Mylan Company Information
- 6.2.2 Mylan Business Overview
- 6.2.3 Mylan Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Mylan Topical Acne Medication Product Portfolio
- 6.2.5 Mylan Recent Developments
- 6.3 GlaxoSmithKline
- 6.3.1 GlaxoSmithKline Company Information
- 6.3.2 GlaxoSmithKline Business Overview
- 6.3.3 GlaxoSmithKline Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GlaxoSmithKline Topical Acne Medication Product Portfolio
- 6.3.5 GlaxoSmithKline Recent Developments
- 6.4 Sun Pharma
- 6.4.1 Sun Pharma Company Information
- 6.4.2 Sun Pharma Business Overview
- 6.4.3 Sun Pharma Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sun Pharma Topical Acne Medication Product Portfolio
- 6.4.5 Sun Pharma Recent Developments
- 6.5 Sine Pharma
- 6.5.1 Sine Pharma Company Information
- 6.5.2 Sine Pharma Business Overview
- 6.5.3 Sine Pharma Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sine Pharma Topical Acne Medication Product Portfolio
- 6.5.5 Sine Pharma Recent Developments
- 6.6 Mayne Pharma
- 6.6.1 Mayne Pharma Company Information
- 6.6.2 Mayne Pharma Business Overview
- 6.6.3 Mayne Pharma Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Mayne Pharma Topical Acne Medication Product Portfolio
- 6.6.5 Mayne Pharma Recent Developments
- 6.7 Lion
- 6.7.1 Lion Company Information
- 6.7.2 Lion Business Overview
- 6.7.3 Lion Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Lion Topical Acne Medication Product Portfolio
- 6.7.5 Lion Recent Developments
- 6.8 HUAPONT
- 6.8.1 HUAPONT Company Information
- 6.8.2 HUAPONT Business Overview
- 6.8.3 HUAPONT Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 HUAPONT Topical Acne Medication Product Portfolio
- 6.8.5 HUAPONT Recent Developments
- 6.9 Galderma
- 6.9.1 Galderma Company Information
- 6.9.2 Galderma Business Overview
- 6.9.3 Galderma Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Galderma Topical Acne Medication Product Portfolio
- 6.9.5 Galderma Recent Developments
- 6.10 Bausch Health
- 6.10.1 Bausch Health Company Information
- 6.10.2 Bausch Health Business Overview
- 6.10.3 Bausch Health Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Bausch Health Topical Acne Medication Product Portfolio
- 6.10.5 Bausch Health Recent Developments
- 6.11 Almirall
- 6.11.1 Almirall Company Information
- 6.11.2 Almirall Business Overview
- 6.11.3 Almirall Topical Acne Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Almirall Topical Acne Medication Product Portfolio
- 6.11.5 Almirall Recent Developments
7 North America
- 7.1 North America Topical Acne Medication Market Size (2021-2032)
- 7.2 North America Topical Acne Medication Market Size by Type
- 7.2.1 North America Topical Acne Medication Market Size by Type (2021-2026)
- 7.2.2 North America Topical Acne Medication Market Size by Type (2027-2032)
- 7.2.3 North America Topical Acne Medication Market Share by Type (2021-2032)
- 7.3 North America Topical Acne Medication Market Size by Application
- 7.3.1 North America Topical Acne Medication Market Size by Application (2021-2026)
- 7.3.2 North America Topical Acne Medication Market Size by Application (2027-2032)
- 7.3.3 North America Topical Acne Medication Market Share by Application (2021-2032)
- 7.4 North America Topical Acne Medication Market Size by Country
- 7.4.1 North America Topical Acne Medication Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Topical Acne Medication Market Size by Country (2021-2026)
- 7.4.3 North America Topical Acne Medication Market Size by Country (2027-2032)
- 7.4.4 North America Topical Acne Medication Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Topical Acne Medication Market Size (2021-2032)
- 8.2 Europe Topical Acne Medication Market Size by Type
- 8.2.1 Europe Topical Acne Medication Market Size by Type (2021-2026)
- 8.2.2 Europe Topical Acne Medication Market Size by Type (2027-2032)
- 8.2.3 Europe Topical Acne Medication Market Share by Type (2021-2032)
- 8.3 Europe Topical Acne Medication Market Size by Application
- 8.3.1 Europe Topical Acne Medication Market Size by Application (2021-2026)
- 8.3.2 Europe Topical Acne Medication Market Size by Application (2027-2032)
- 8.3.3 Europe Topical Acne Medication Market Share by Application (2021-2032)
- 8.4 Europe Topical Acne Medication Market Size by Country
- 8.4.1 Europe Topical Acne Medication Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Topical Acne Medication Market Size by Country (2021-2026)
- 8.4.3 Europe Topical Acne Medication Market Size by Country (2027-2032)
- 8.4.4 Europe Topical Acne Medication Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Topical Acne Medication Market Size (2021-2032)
- 9.2 China Topical Acne Medication Market Size by Type
- 9.2.1 China Topical Acne Medication Market Size by Type (2021-2026)
- 9.2.2 China Topical Acne Medication Market Size by Type (2027-2032)
- 9.2.3 China Topical Acne Medication Market Share by Type (2021-2032)
- 9.3 China Topical Acne Medication Market Size by Application
- 9.3.1 China Topical Acne Medication Market Size by Application (2021-2026)
- 9.3.2 China Topical Acne Medication Market Size by Application (2027-2032)
- 9.3.3 China Topical Acne Medication Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Topical Acne Medication Market Size (2021-2032)
- 10.2 Asia Topical Acne Medication Market Size by Type
- 10.2.1 Asia Topical Acne Medication Market Size by Type (2021-2026)
- 10.2.2 Asia Topical Acne Medication Market Size by Type (2027-2032)
- 10.2.3 Asia Topical Acne Medication Market Share by Type (2021-2032)
- 10.3 Asia Topical Acne Medication Market Size by Application
- 10.3.1 Asia Topical Acne Medication Market Size by Application (2021-2026)
- 10.3.2 Asia Topical Acne Medication Market Size by Application (2027-2032)
- 10.3.3 Asia Topical Acne Medication Market Share by Application (2021-2032)
- 10.4 Asia Topical Acne Medication Market Size by Country
- 10.4.1 Asia Topical Acne Medication Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Topical Acne Medication Market Size by Country (2021-2026)
- 10.4.3 Asia Topical Acne Medication Market Size by Country (2027-2032)
- 10.4.4 Asia Topical Acne Medication Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Topical Acne Medication Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Topical Acne Medication Market Size by Type
- 11.2.1 South America, Middle East & Africa Topical Acne Medication Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Topical Acne Medication Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Topical Acne Medication Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Topical Acne Medication Market Size by Application
- 11.3.1 South America, Middle East & Africa Topical Acne Medication Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Topical Acne Medication Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Topical Acne Medication Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Topical Acne Medication Market Size by Country
- 11.4.1 South America, Middle East & Africa Topical Acne Medication Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Topical Acne Medication Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Topical Acne Medication Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Topical Acne Medication Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst